Lindbrook Capital, LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 184 filers reported holding FIBROGEN INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q2 2023$105
-99.0%
39
-93.2%
0.00%
-100.0%
Q1 2023$10,692
-7.8%
573
-20.9%
0.00%0.0%
Q4 2022$11,598
+286.6%
724
+246.4%
0.00%0.0%
Q3 2022$3,000
+50.0%
209
+22.9%
0.00%
Q2 2022$2,000
-88.2%
170
-66.0%
0.00%
-100.0%
Q1 2021$17,000
-19.0%
5000.0%0.00%
-42.9%
Q4 2019$21,000
-22.2%
5000.0%0.01%
-36.4%
Q1 2019$27,000
+200.0%
500
+150.0%
0.01%
+175.0%
Q4 2018$9,0002000.00%
Other shareholders
FIBROGEN INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders